The authors noted that common CYP2C19 LoF variants may account for the effectiveness of dual therapy over clopidogrel monotherapy.32 In our study, we found LoF carriers still had increased stroke or MI risk, even if coprescribed aspirin. This evidence concerns the gene CYP2C19 and stroke disorder.